Author Correction: A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis. (2020)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-020-61783-9
PubMed Identifier: 32152372
Publication URI: http://europepmc.org/abstract/MED/32152372
Type: Journal Article/Review
Volume: 10
Parent Publication: Scientific reports
Issue: 1
ISSN: 2045-2322